JP2023518376A - 気道感染症を治療するための組成物およびそれらの使用 - Google Patents

気道感染症を治療するための組成物およびそれらの使用 Download PDF

Info

Publication number
JP2023518376A
JP2023518376A JP2022555836A JP2022555836A JP2023518376A JP 2023518376 A JP2023518376 A JP 2023518376A JP 2022555836 A JP2022555836 A JP 2022555836A JP 2022555836 A JP2022555836 A JP 2022555836A JP 2023518376 A JP2023518376 A JP 2023518376A
Authority
JP
Japan
Prior art keywords
seq
peptide
formula
group
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022555836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518376A5 (cg-RX-API-DMAC7.html
Inventor
アンドリュー、ギアリング
デイビッド、ケンリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lateral IP Pty Ltd
Original Assignee
Lateral IP Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2020900807A external-priority patent/AU2020900807A0/en
Application filed by Lateral IP Pty Ltd filed Critical Lateral IP Pty Ltd
Publication of JP2023518376A publication Critical patent/JP2023518376A/ja
Publication of JP2023518376A5 publication Critical patent/JP2023518376A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2257—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57554—Prolactin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
JP2022555836A 2020-03-16 2021-03-16 気道感染症を治療するための組成物およびそれらの使用 Withdrawn JP2023518376A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2020900807A AU2020900807A0 (en) 2020-03-16 Compositions for treating respiratory tract infection and uses thereof
AU2020900807 2020-03-16
AU2020900818 2020-03-17
AU2020900818A AU2020900818A0 (en) 2020-03-17 Compositions for treating respiratory tract infection and uses thereof
AU2020904226 2020-11-16
AU2020904226A AU2020904226A0 (en) 2020-11-16 Compositions for treating respiratory tract infection and uses thereof
PCT/AU2021/050229 WO2021184062A1 (en) 2020-03-16 2021-03-16 Compositions for treating respiratory tract infection and uses thereof

Publications (2)

Publication Number Publication Date
JP2023518376A true JP2023518376A (ja) 2023-05-01
JP2023518376A5 JP2023518376A5 (cg-RX-API-DMAC7.html) 2024-03-27

Family

ID=77767913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022555836A Withdrawn JP2023518376A (ja) 2020-03-16 2021-03-16 気道感染症を治療するための組成物およびそれらの使用

Country Status (7)

Country Link
US (1) US20230256059A1 (cg-RX-API-DMAC7.html)
EP (1) EP4121084A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023518376A (cg-RX-API-DMAC7.html)
CN (1) CN115297882A (cg-RX-API-DMAC7.html)
AU (1) AU2021237981A1 (cg-RX-API-DMAC7.html)
CA (1) CA3171917A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021184062A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3996737A4 (en) * 2019-07-09 2023-06-14 Lateral Ip Pty Ltd PEPTIDES AND THEIR USES
US20250255934A1 (en) * 2021-05-07 2025-08-14 Lateral IP Pty Ltd Compositions for treating inflammatory airway disease and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20080333A0 (fi) * 2008-05-02 2008-05-02 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
KR102148910B1 (ko) * 2011-12-09 2020-08-28 메타볼릭 파마슈티칼즈 피티와이 엘티디 성장 호르몬 단편들의 사용
US9139626B2 (en) * 2012-09-13 2015-09-22 The Mitre Corporation Mitrecin A polypeptide with antimicrobial activity
WO2019136528A1 (en) * 2018-01-15 2019-07-18 Lateral IP Pty Ltd Peptides and uses thereof
JP7751583B2 (ja) * 2019-12-27 2025-10-08 ラテラル、アイピー、プロプライエタリー、リミテッド 環状ペプチド受容体ランチオニンシンテターゼc様タンパク質(lancl)及びその使用

Also Published As

Publication number Publication date
EP4121084A4 (en) 2024-04-03
AU2021237981A1 (en) 2022-10-13
US20230256059A1 (en) 2023-08-17
CA3171917A1 (en) 2021-09-23
WO2021184062A1 (en) 2021-09-23
EP4121084A1 (en) 2023-01-25
CN115297882A (zh) 2022-11-04

Similar Documents

Publication Publication Date Title
US20150018396A1 (en) Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist
ES3055494T3 (en) Treatment of respiratory diseases
CN114786659A (zh) 用于治疗汉坦病毒感染的mek抑制剂
JP2013532729A5 (cg-RX-API-DMAC7.html)
CA2817787C (en) Composition comprising a peptide and an inhibitor of viral neuraminidase
US12630589B2 (en) Compounds for use in viral infections
US20230256059A1 (en) Compositions for treating respiratory tract infection and uses thereof
CA2886270C (en) Esters of short chains fatty acids for use in the treatment of immunogenic disorders
JP2018519333A (ja) ウイルス感染の治療のための組成物および方法
US11304989B2 (en) Peptides for use in the treatment of viral infections
CN110769843A (zh) C5a受体激动剂肽的盐酸盐
KR20240036634A (ko) 란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도
US20250255934A1 (en) Compositions for treating inflammatory airway disease and uses thereof
JP6178058B2 (ja) 抗炎症及び/又は抗ヒスタミン剤組成物
US12492223B2 (en) Peptide compositions capable of binding lanthionine synthetase C-like protein (LanCl) and uses thereof
ES2353128T3 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de la leucomalacia periventricular.
JP2022553703A5 (cg-RX-API-DMAC7.html)
CN103169970A (zh) 一种治疗病毒性肺炎的药物组合物
WO2021202745A1 (en) Treatment of covid-19 with a sine compound
WO2025129029A2 (en) Combinations of foralumab with glucagon-like peptide 1 (glp-1) agonists or sodium-glucose cotransporter-2 (sglt2) inhibitors and methods of use thereof
RU2498797C2 (ru) Комбинированное средство для лечения гриппа и орви
TW202340237A (zh) 尼塞韋單抗預防呼吸道融合細胞病毒下呼吸道感染
EA053309B1 (ru) Предупреждение инфекции нижнего респираторного тракта, вызываемой респираторно-синцитиальным вирусом, с помощью нирсевимаба
CN111655251A (zh) 用于治疗鼻病毒的羟基苯甲酸的酯
Recto et al. A REVIEW OF IMMUNOMODULATORS AS THERAPEUTIC INTERVENTIONS FOR MODERATE TO SEVERE COVID-19 INFECTIONS (April 20, 2020)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240315

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20241212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241212